HPV16 vaccine shows promise in treating precancerous cervical lesions

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Medios acquires Dutch market leader in pharmaceutical compounding services – Biotech Investments

Medios AG / Key word(s): Mergers & Acquisitions/Expansion Medios acquires Dutch market leader in pharmaceutical compounding services 18-March-2024 / 20:41 CET/CEST Disclosure of an inside

March 19, 2024

AstraZeneca, Amgen tout Phase 2a Tezspire data in COPD ahead of Dupixent decision

AstraZeneca and Amgen laid out the full Phase 2a dataset for Tezspire in COPD at the American Thoracic Society’s International Conference on Sunday, providing a

May 21, 2024

KLAS: State of Virtual Sitting & Nursing Market Insights 2023

What You Should Know: Virtual sitting and virtual nursing solutions are receiving attention from healthcare organizations. Although the use of virtual nursing especially is not

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.